Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-16

FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (Aarkish Pharmaceuticals NJ Inc.)

View source ↗

Summary

FDA approved an original application for a generic butalbital and acetaminophen product from Aarkish Pharmaceuticals NJ Inc., authorizing its marketing in the U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL AND ACETAMINOPHEN (Butalbital; Acetaminophen)

Snippet

ORIG AP for BUTALBITAL AND ACETAMINOPHEN (BUTALBITAL AND ACETAMINOPHEN)